Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Novartis
Cipla
Queensland Health
Moodys
Julphar
Accenture
Chubb
Deloitte

Generated: October 23, 2017

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and thirteen approved drugs.



Summary for Applicant: Abbott

US Patents:0
Tradenames:91
Ingredients:64
NDAs:113
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride
INJECTABLE;INJECTION080386-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
GENTAMICIN SULFATE
gentamicin sulfate
INJECTABLE;INJECTION062413-010Aug 11, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION019713-002Sep 9, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION089580-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
LOPURIN
allopurinol
TABLET;ORAL018297-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
CEPHALOTHIN SODIUM
cephalothin sodium
INJECTABLE;INJECTION062547-001Sep 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION019713-005Sep 9, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
CYLERT
pemoline
TABLET, CHEWABLE;ORAL017703-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
IBUPROFEN
ibuprofen
TABLET;ORAL071264-001Jul 25, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
VERCYTE
pipobroman
TABLET;ORAL016245-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-001Aug 7, 1987► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-003Aug 7, 1987► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-003Dec 14, 1994► Subscribe► Subscribe
Abbott
TRAVASE
sutilains
OINTMENT;TOPICAL012828-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-004Aug 7, 1987► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 1994► Subscribe► Subscribe
Abbott
DEPAKOTE CP
divalproex sodium
TABLET, DELAYED RELEASE;ORAL019794-002Jul 11, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ABBOTT drugs

Drugname Dosage Strength Tradename Submissiondate
ritonavir
Capsules100 mg
NORVIR
10/31/2012
ritonavir
Tablets100 mg
NORVIR
12/21/2010
sibutramine hydrochloride
Capsules10 mg and 15 mg
MERIDIA
8/14/2009

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Novartis
QuintilesIMS
Boehringer Ingelheim
Cantor Fitzgerald
Federal Trade Commission
UBS
Teva
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot